{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:36:27Z","timestamp":1788971787292,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,25]]},"DOI":"10.7759\/cureus.51076","type":"journal-article","created":{"date-parts":[[2023,12,25]],"date-time":"2023-12-25T16:52:45Z","timestamp":1703523165000},"source":"Crossref","is-referenced-by-count":5,"title":["Nutritional and Wellness Strategies for Neurological and Psychiatric Recovery From Post-COVID Syndrome and Post-acute Sequelae of COVID-19"],"prefix":"10.7759","author":[{"given":"Jeffrey","family":"Schaefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepesh","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"WHO Coronavirus (COVID-19) Dashboard. (2023). Accessed. December 1, 2023: https:\/\/covid19.who.int\/."},{"key":"ref2","unstructured":"COVID Data Tracker. (2023). Accessed. December 1, 2023: https:\/\/covid.cdc.gov\/covid-data-tracker\/#datatracker-home."},{"key":"ref3","unstructured":"CDC Science behind Long COVID. (2023). Accessed. December 1, 2023: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-care\/post-covid-science.html."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45231","article-title":"The lasting effects of COVID-19 on the progression of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"15","author":"Backer S","year":"2023","unstructured":"Backer S, Khanna D. The lasting effects of COVID-19 on the progression of metabolic dysfunction-associated steatotic liver disease (MASLD). Cureus. 2023, 15:e45231. 10.7759\/cureus.45231","journal-title":"Cureus"},{"key":"ref5","article-title":"Long COVID syndrome: a scoping review","author":"Sobczak A","year":"2022","unstructured":"Sobczak A, Castellano B, Castellano C, Khanna D. Long COVID syndrome: a scoping review. APHA. 2022,","journal-title":"APHA"},{"key":"ref6","article-title":"Neurological complications of COVID-19 infection","author":"Brauer T","year":"2022","unstructured":"Brauer T, Khanna D. Neurological complications of COVID-19 infection. APHA. 2022,","journal-title":"APHA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2021.03.010","article-title":"Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals","volume":"52","author":"Pavli A","year":"2021","unstructured":"Pavli A, Theodoridou M, Maltezou HC. Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals. Arch Med Res. 2021, 52:575-81. 10.1016\/j.arcmed.2021.03.010","journal-title":"Arch Med Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51350","article-title":"Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 \"long haulers\"","volume":"8","author":"Graham EL","year":"2021","unstructured":"Graham EL, Clark JR, Orban ZS, et al.. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 \"long haulers\". Ann Clin Transl Neurol. 2021, 8:1073-85. 10.1002\/acn3.51350","journal-title":"Ann Clin Transl Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28530","article-title":"Laboratory and point-of-care testing for COVID- 19: a review of recent developments","volume":"14","author":"Kalia R","year":"2022","unstructured":"Kalia R, Kaila R, Kahar P, Khanna D. Laboratory and point-of-care testing for COVID- 19: a review of recent developments\r\n. Cureus. 2022, 14:e28530. 10.7759\/cureus.28530","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27438","article-title":"A review of COVID-19 in relation to metabolic syndrome: obesity, hypertension, diabetes, and dyslipidemia","volume":"14","author":"Makhoul E","year":"2022","unstructured":"Makhoul E, Aklinski JL, Miller J, et al.. A review of COVID-19 in relation to metabolic syndrome: obesity, hypertension, diabetes, and dyslipidemia. Cureus. 2022, 14:e27438. 10.7759\/cureus.27438","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22491","article-title":"Socioeconomic determinants of COVID-19 incidence and mortality in Florida","volume":"14","author":"Backer S","year":"2022","unstructured":"Backer S, Rezene A, Kahar P, Khanna D. Socioeconomic determinants of COVID-19 incidence and mortality in Florida. Cureus. 2022, 14:e22491. 10.7759\/cureus.22491","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30555","article-title":"Effects of COVID-19 on pregnant women and newborns: a review","volume":"14","author":"Patel BM","year":"2022","unstructured":"Patel BM, Khanna D, Khanna S, Hapshy V, Khanna P, Kahar P, Parmar MS. Effects of COVID-19 on pregnant women and newborns: a review. Cureus. 2022, 14:e30555. 10.7759\/cureus.30555","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.2002083","article-title":"A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson","volume":"18","author":"Patel R","year":"2022","unstructured":"Patel R, Kaki M, Potluri VS, Kahar P, Khanna D. A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson. Hum Vaccin Immunother. 2022, 18:2002083. 10.1080\/21645515.2021.2002083","journal-title":"Hum Vaccin Immunother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33740","article-title":"The role of vitamin C in human immunity and its treatment potential against COVID- 19: a review article","volume":"15","author":"Moore A","year":"2023","unstructured":"Moore A, Khanna D. The role of vitamin C in human immunity and its treatment potential against COVID- 19: a review article\r\n. Cureus. 2023, 15:e33740. 10.7759\/cureus.33740","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32437","article-title":"A survey of public health failures during COVID-19","volume":"14","author":"Dominquez BC","year":"2022","unstructured":"Dominquez BC, Hernandez A, Fernandez-Pacheco A, Taylor L, Kahar P, Khanna D. A survey of public health failures during COVID-19. Cureus. 2022, 14:e32437. 10.7759\/cureus.32437","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105542","article-title":"Transcranial doppler ultrasound evidence of active cerebral embolization in COVID-19","volume":"30","author":"Batra A","year":"2021","unstructured":"Batra A, Clark JR, LaHaye K, et al.. Transcranial doppler ultrasound evidence of active cerebral embolization in COVID-19. J Stroke Cerebrovasc Dis. 2021, 30:105542. 10.1016\/j.jstrokecerebrovasdis.2020.105542","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2021.0225","article-title":"Assessing brain capillaries in coronavirus disease 2019","volume":"78","author":"Nauen DW","year":"2021","unstructured":"Nauen DW, Hooper JE, Stewart CM, Solomon IH. Assessing brain capillaries in coronavirus disease 2019. JAMA Neurol. 2021, 78:760-2. 10.1001\/jamaneurol.2021.0225","journal-title":"JAMA Neurol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.04.007","article-title":"Long COVID: an overview","volume":"15","author":"Raveendran AV","year":"2021","unstructured":"Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. 2021, 15:869-75. 10.1016\/j.dsx.2021.04.007","journal-title":"Diabetes Metab Syndr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202101_24683","article-title":"Pathogenesis of dysgeusia in COVID-19 patients: a scoping review","volume":"25","author":"Mahmoud MM","year":"2021","unstructured":"Mahmoud MM, Abuohashish HM, Khairy DA, Bugshan AS, Khan AM, Moothedath MM. Pathogenesis of dysgeusia in COVID-19 patients: a scoping review. Eur Rev Med Pharmacol Sci. 2021, 25:1114-34. 10.26355\/eurrev_202101_24683","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-021-02696-0","article-title":"Could SARS-CoV-2 Spike protein be responsible for long-COVID syndrome?","volume":"59","author":"Theoharides TC","year":"2022","unstructured":"Theoharides TC. Could SARS-CoV-2 Spike protein be responsible for long-COVID syndrome?. Mol Neurobiol. 2022, 59:1850-61. 10.1007\/s12035-021-02696-0","journal-title":"Mol Neurobiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.69314","article-title":"Effect of SARS-CoV-2 proteins on vascular permeability","volume":"10","author":"Rauti R","year":"2021","unstructured":"Rauti R, Shahoha M, Leichtmann-Bardoogo Y, et al.. Effect of SARS-CoV-2 proteins on vascular permeability. Elife. 2021, 10:69314. 10.7554\/eLife.69314","journal-title":"Elife"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne A","year":"2015","unstructured":"Montagne A, Barnes SR, Sweeney MD, et al.. Blood-brain barrier breakdown in the aging human hippocampus. Neuron. 2015, 85:296-302. 10.1016\/j.neuron.2014.12.032","journal-title":"Neuron"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-066452","article-title":"Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial","volume":"376","author":"Hahn J","year":"2022","unstructured":"Hahn J, Cook NR, Alexander EK, et al.. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 2022, 376:e066452. 10.1136\/bmj-2021-066452","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2020.1794819","article-title":"The use of IV vitamin C for patients with COVID-19: a case series","volume":"18","author":"Hiedra R","year":"2020","unstructured":"Hiedra R, Lo KB, Elbashabsheh M, et al.. The use of IV vitamin C for patients with COVID-19: a case series. Expert Rev Anti Infect Ther. 2020, 18:1259-61. 10.1080\/14787210.2020.1794819","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15r09984","article-title":"N-acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis","volume":"77","author":"Fernandes BS","year":"2016","unstructured":"Fernandes BS, Dean OM, Dodd S, Malhi GS, Berk M. N-acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis. J Clin Psychiatry. 2016, 77:e457-66. 10.4088\/JCP.15r09984","journal-title":"J Clin Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12370","article-title":"N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial","volume":"41","author":"Paydary K","year":"2016","unstructured":"Paydary K, Akamaloo A, Ahmadipour A, Pishgar F, Emamzadehfard S, Akhondzadeh S. N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial. J Clin Pharm Ther. 2016, 41:214-9. 10.1111\/jcpt.12370","journal-title":"J Clin Pharm Ther"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-021-02997-4","article-title":"COVID-19 and selenium deficiency: a systematic review","volume":"200","author":"Fakhrolmobasheri M","year":"2022","unstructured":"Fakhrolmobasheri M, Mazaheri-Tehrani S, Kieliszek M, Zeinalian M, Abbasi M, Karimi F, Mozafari AM. COVID-19 and selenium deficiency: a systematic review\r\n. Biol Trace Elem Res. 2022, 200:3945-56. 10.1007\/s12011-021-02997-4","journal-title":"Biol Trace Elem Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910559","article-title":"Vitamin D and COVID-19: an overview of recent evidence","volume":"22","author":"Ghelani D","year":"2021","unstructured":"Ghelani D, Alesi S, Mousa A. Vitamin D and COVID-19: an overview of recent evidence. Int J Mol Sci. 2021, 22:10559. 10.3390\/ijms221910559","journal-title":"Int J Mol Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02958-4","article-title":"Regarding: \"the effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial\"","volume":"19","author":"Nakata T","year":"2021","unstructured":"Nakata T, Ariie T, Taito S. Regarding: \"the effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial\". J Transl Med. 2021, 19:282. 10.1186\/s12967-021-02958-4","journal-title":"J Transl Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2013.108","article-title":"Omega-3 polyunsaturated fatty acid supplementation improves neurologic recovery and attenuates white matter injury after experimental traumatic brain injury","volume":"33","author":"Pu H","year":"2013","unstructured":"Pu H, Guo Y, Zhang W, et al.. Omega-3 polyunsaturated fatty acid supplementation improves neurologic recovery and attenuates white matter injury after experimental traumatic brain injury. J Cereb Blood Flow Metab. 2013, 33:1474-84. 10.1038\/jcbfm.2013.108","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.5.1211","article-title":"Relationship between C-reactive protein and glucose levels in community-dwelling subjects without diabetes: the Hisayama Study","volume":"28","author":"Doi Y","year":"2005","unstructured":"Doi Y, Kiyohara Y, Kubo M, et al.. Relationship between C-reactive protein and glucose levels in community-dwelling subjects without diabetes: the Hisayama Study. Diabetes Care. 2005, 28:1211-3. 10.2337\/diacare.28.5.1211","journal-title":"Diabetes Care"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/nu10060761","article-title":"High-glucose or -fructose diet cause changes of the gut microbiota and metabolic disorders in mice without body weight change","volume":"10","author":"Do MH","year":"2018","unstructured":"Do MH, Lee E, Oh MJ, Kim Y, Park HY. High-glucose or -fructose diet cause changes of the gut microbiota and metabolic disorders in mice without body weight change. Nutrients. 2018, 10:761. 10.3390\/nu10060761","journal-title":"Nutrients"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13128","article-title":"Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships","volume":"21","author":"Popkin BM","year":"2020","unstructured":"Popkin BM, Du S, Green WD, et al.. Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev. 2020, 21:e13128. 10.1111\/obr.13128","journal-title":"Obes Rev"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325989","article-title":"Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome","volume":"71","author":"Liu Q","year":"2022","unstructured":"Liu Q, Mak JW, Su Q, et al.. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022, 71:544-52. 10.1136\/gutjnl-2021-325989","journal-title":"Gut"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.12.025","article-title":"Skeletal muscle PGC-1\u03b11 modulates kynurenine metabolism and mediates resilience to stress-induced depression","volume":"160","author":"Agudelo Leandro Z","year":"2015","unstructured":"Agudelo Leandro Z, Femen\u00eda T, Orhan F, et al.. Skeletal muscle PGC-1\u03b11 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell. 2015, 160:351. 10.1016\/j.cell.2014.12.025","journal-title":"Cell"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10121960","article-title":"Increased Kynurenine indicates a fatal course of COVID-19","volume":"10","author":"Mangge H","year":"2021","unstructured":"Mangge H, Herrmann M, Meinitzer A, et al.. Increased Kynurenine indicates a fatal course of COVID-19. Antioxidants (Basel). 2021, 10:1960. 10.3390\/antiox10121960","journal-title":"Antioxidants (Basel)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-180959","article-title":"The association between mushroom consumption and mild cognitive impairment: A community-based cross-sectional study in Singapore","volume":"68","author":"Feng L","year":"2019","unstructured":"Feng L, Cheah IK, Ng MM, et al.. The association between mushroom consumption and mild cognitive impairment: A community-based cross-sectional study in Singapore. J Alzheimers Dis. 2019, 68:197-203. 10.3233\/JAD-180959","journal-title":"J Alzheimers Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102576","article-title":"Mushrooms and immunity","volume":"117","author":"Motta F","year":"2021","unstructured":"Motta F, Gershwin ME, Selmi C. Mushrooms and immunity. J Autoimmun. 2021, 117:102576. 10.1016\/j.jaut.2020.102576","journal-title":"J Autoimmun"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-021-00546-8","article-title":"Neurogenesis-dependent antidepressant-like activity of Hericium erinaceus in an animal model of depression","volume":"16","author":"Chong PS","year":"2021","unstructured":"Chong PS, Poon CH, Roy J, et al.. Neurogenesis-dependent antidepressant-like activity of Hericium erinaceus in an animal model of depression. Chin Med. 2021, 16:132. 10.1186\/s13020-021-00546-8","journal-title":"Chin Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1093\/advances\/nmab015","article-title":"Higher mushroom consumption is associated with lower risk of cancer: a systematic review and meta-analysis of observational studies","volume":"12","author":"Ba DM","year":"2021","unstructured":"Ba DM, Ssentongo P, Beelman RB, Muscat J, Gao X, Richie JP. Higher mushroom consumption is associated with lower risk of cancer: a systematic review and meta-analysis of observational studies. Adv Nutr. 2021, 12:1691-704. 10.1093\/advances\/nmab015","journal-title":"Adv Nutr"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11010124","article-title":"Potential therapeutic use of the rosemary diterpene carnosic acid for Alzheimer\u2019s disease, Parkinson\u2019s disease, and Long-COVID through NRF2 activation to counteract the NLRP3 inflammasome","volume":"11","author":"Satoh T","year":"2022","unstructured":"Satoh T, Trudler D, Oh CK, Lipton SA. Potential therapeutic use of the rosemary diterpene carnosic acid for Alzheimer\u2019s disease, Parkinson\u2019s disease, and Long-COVID through NRF2 activation to counteract the NLRP3 inflammasome. Antioxidants (Basel). 2022, 11:124. 10.3390\/antiox11010124","journal-title":"Antioxidants (Basel)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2019.1612103","article-title":"The impact of whole-body hyperthermia interventions on mood and depression - are we ready for recommendations for clinical application?","volume":"36","author":"Hanusch KU","year":"2019","unstructured":"Hanusch KU, Janssen CW. The impact of whole-body hyperthermia interventions on mood and depression - are we ready for recommendations for clinical application?. Int J Hyperthermia. 2019, 36:573-81. 10.1080\/02656736.2019.1612103","journal-title":"Int J Hyperthermia"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.5604\/12321966.1233977","article-title":"Effects of sauna bathing on stress-related genes expression in athletes and non-athletes","volume":"24","author":"Zychowska M","year":"2017","unstructured":"Zychowska M, P\u00f3\u0142rola P, Chru\u015bci\u0144ski G, Zieli\u0144ska J, G\u00f3ral-P\u00f3\u0142rola J. Effects of sauna bathing on stress-related genes expression in athletes and non-athletes. Ann Agric Environ Med. 2017, 24:104-7. 10.5604\/12321966.1233977","journal-title":"Ann Agric Environ Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/174640-nutritional-and-wellness-strategies-for-neurological-and-psychiatric-recovery-from-post-covid-syndrome-and-post-acute-sequelae-of-covid-19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:12Z","timestamp":1707509532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/174640-nutritional-and-wellness-strategies-for-neurological-and-psychiatric-recovery-from-post-covid-syndrome-and-post-acute-sequelae-of-covid-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,25]]},"references-count":43,"URL":"https:\/\/doi.org\/10.7759\/cureus.51076","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,25]]}}}